Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
22,990,194
-
Share change
-
+1,216,778
-
Total reported value
-
$1,055,473,346
-
Put/Call ratio
-
135%
-
Price per share
-
$45.93
-
Number of holders
-
351
-
Value change
-
+$47,100,819
-
Number of buys
-
139
-
Number of sells
-
263
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q1 2022
As of 31 Mar 2022,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
351 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,990,194 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, WELLS FARGO & COMPANY/MN, Matrix Capital Management Company, LP, LPL Financial LLC, UBS Group AG, COMMONWEALTH EQUITY SERVICES, LLC, STATE OF WISCONSIN INVESTMENT BOARD, and BNP PARIBAS ARBITRAGE, SA.
This page lists
356
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.